Acute and chronic allograft dysfunction following pediatric lung transplantation

Area of Science:

• Pediatric Pulmonology
• Transplant Surgery
• Immunology

Background:

• Pediatric lung transplantation offers a life-saving option for end-stage lung disease.
• Improved immunosuppression and treatments have enhanced survival outcomes.
• Key challenges remain, including acute rejection, infection, and chronic lung allograft dysfunction (CLAD).

Purpose of the Study:

• To review early complications and mechanisms of acute allograft dysfunction in pediatric lung transplantation.
• To explore current prevention and treatment strategies for acute dysfunction.
• To detail chronic lung allograft dysfunction (CLAD), including subtypes, risk factors, diagnostics, and future research directions.

Main Methods:

• Literature review focusing on early complications and CLAD in pediatric lung transplantation.
• Exploration of underlying mechanisms of acute allograft dysfunction.
• Analysis of current prevention, treatment, and diagnostic strategies for CLAD.

Main Results:

• Understanding of acute and CLAD has evolved, leading to improved prevention and treatment strategies.
• Infection and aspiration are key risk factors requiring careful management.
• Diagnosis of CLAD remains challenging, with limited effective treatment options.

Conclusions:

• Prevention and treatment strategies for acute and chronic lung allograft dysfunction have advanced.
• Accurate diagnosis and effective treatment for CLAD are significant unmet needs.
• Future research should prioritize the prevention and improved characterization of CLAD in pediatric lung transplant recipients.